TL

Tiffany Le

Principal at New Enterprise Associates (NEA)

San Francisco, California

Overview

Work Experience

NE

New Enterprise Associates (NEA)

  • Principal

    2020 - Current

    Invest across medtech, healthtech, and the intersection of technology and life sciences. Board Director: Allay Therapeutics, Amber Therapeutics, FIRE1/Norm Labs, Magenta Medical, Revelle Aesthetics, ExploraMed (incubator), X9 (stealth) Board Observer: Moximed, Setpoint Medical, Willow Past/Exited: Relievant (Medtronic Acq.), Eargo (Nasdaq: EAR), Vesper (Philips Acq.), Intact Vascular (Philips Acq.)

KP

Kaiser Permanente Ventures

  • Investor

    2019 - 2020

GE Ventures

  • Healthcare Investments, Summer MBA Intern

    2018 - 2018

A

Amgen

  • Drug Delivery, Design Thinking, & Patient Experience

    2017 - 2017

    Externship while at LEK

LC

L.E.K. Consulting

  • Senior Consultant, Life Sciences

    2015 - 2017

    Managed teams of Associates and Life Science Specialists in strategic projects (M&A, pipeline optimization, product launch, and international expansion) across pharma, medtech, diagnostics, and digital health. Particular focus on personalized medicine and novel therapeutics

  • Senior Associate Consultant, Life Sciences

    2014 - 2015

    Early promotion (2-year role)

  • Associate

    2012 - 2014

    Early promotion (2-year role)

Education

Investments

Amber Therapeutics

Series A

Total Funding: $100M

Relevant Websites